The study covers a detailed analysis segmented by key business segments i.e. , by application (Adult and Pediatric) and major geographies.
What is Collagen Meniscus Implant?
Collagen meniscus implants are used to restore and strengthen soft tissue damage to the medial meniscus during surgical procedures. Collagen meniscus implants are biodegradable and biocompatible scaffolds designed to repair meniscus defects and injuries in people of all ages. Collagen meniscus implants are used to treat a number of disorders, including meniscus tissue loss, partial meniscectomy, acute or chronic post-traumatic meniscus tears, and meniscus damage that necessitates removal of more than 25% of the meniscus. The most common intra-articular injury in the knee is meniscal tears. Meniscal lesions are affecting an increasing number of people around the world. Because of their involvement in activities, young and physically active people are more likely to develop lesions or partial lesions. These have a significant impact on the mobility and function of the knee joints, as well as increasing the incidence of arthritis in the younger population. The collagen meniscus implant is expected to rise in popularity due to rising demand for specialist orthopaedic clinics in emerging and developed markets to treat meniscus tears.
The competition is expected to become even more intense in the years to come due to entry of several new players in the market. To help clients improve their revenue shares in the market, this research study provides an in-depth analysis of the markets competitive landscape and offers information on the products offered by various leading companies. Additionally, this Collagen Meniscus Implant market analysis report suggests strategies Players can follow and recommends key areas they should focus on, in order to take maximum benefits of growth opportunities.
The report offers several leading Players, including:
- Stryker Corporation (United States)
- RTI Surgical (United States)
- Zimmer Biomet (United States)
- Active Implants (United Kingdom)
- Orthonika (United Kingdom)
- Biofixt (Belgium)
The Centers for Medicare and Medicaid Services (CMS) has concluded that the collagen meniscus implant does not improve health outcomes in the Medicare population. Therefore, CMS has determined that the collagen meniscus implant is not reasonable and necessary for the treatment of meniscal injury/tear and we are issuing a national non-coverage determination under §1862(a)(1)(A) of the Social Security Act.
Rising Incidence and Prevalence of Sports and Knee-Related Injuries
Growing Investment on Healthcare Infrastructure and Increased Spending by Individual on Health
Key highlights of the Global Collagen Meniscus Implant market Study:
CAGR of the market during the forecast period 2020-2026
Detailed information on factors that will accelerate the growth of the Collagen Meniscus Implant market for the next five years.
Forecast of the Global Collagen Meniscus Implant market size and its contribution to the parent market by type, application and by country.
Insights on upcoming trends and changes in consumer behaviour
Uncovering markets competitive landscape and in-depth information on various Players
Comprehensive information about factors that will challenge the growth of Collagen Meniscus Implant Players
Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Collagen Meniscus Implant market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Collagen Meniscus Implant market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment> by targeting key target audience that includes Collagen Meniscus Implants Treatment Providers, Healthcare Industry, Pharmaceutical Company, Research & Development Centers and Others.
This helps us to gather the data for the players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases etc.